Landmark Group organizes its 6th annual Blood donation campaignAME Info (press release)In line with its year-round corporate responsibility strategy Landmark Group, the largest value retail shopping chain in Kuwait recently conducted its sixth annual b…
Discovery could speed up heart failure and pneumonia diagnosis – Medical Xpress
|
Discovery could speed up heart failure and pneumonia diagnosis
Medical Xpress Associate Professor Chris Pemberton and colleagues at the University’s Christchurch Heart Institute have found that the molecule ghrelin signal peptide (GHRsp) could be used to signal if patients have concomitant heart failure and pneumonia. The study … |
Lifetime Risks For Heart Failure Similar In Both White And Black Races – RedOrbit
RedOrbitLifetime Risks For Heart Failure Similar In Both White And Black RacesRedOrbitA new study from researchers at Northwestern University has found that lifetime risk for heart failure is similar for blacks and whites. The study also found that in …
Biogen Idec completa la adquisición de todos los derechos y control de TYSABRI® – Lainformacion.com
|
Biogen Idec completa la adquisición de todos los derechos y control de TYSABRI®
Lainformacion.com Biogen Idec también cuenta con la cartera de EM más completa del sector con compuestos que incluyen PLEGRIDY (peginterferón beta-1a); el proceso de alto rendimiento de daclizumab (DAC HYP) para la administración subcutánea mensual; y un estudio … |
Messi scare puts spotlight on Barca's misfiring strikers – Times of India
 IANS |
Messi scare puts spotlight on Barca’s misfiring strikers
Times of India The versatile Eric Abidal has just returned to the side a year after having a liver transplant and has yet to play a competitive match. Another option is to convert holding midfielders Sergio Busquets or Alex Song into centre-backs, which has been … Barcelona may well win the battle, but decimated defence means they might not …Goal.com India Messi, Mascherano hurt as Barca play draw in ParisIANS |
Omeros Announces Positive OMS721 Data in Model of Thrombotic … – PipelineReview.com (press release)
|
Omeros Announces Positive OMS721 Data in Model of Thrombotic …
PipelineReview.com (press release) SEATTLE, WA, USA I April 2, 2013 I Omeros Corporation (OMER) today announced positive data using OMS721, the lead human monoclonal antibody in Omeros’ mannan-binding lectin-associated serine protease-2 (MASP-2) program, in a well-established … |
New Study Likely to Change Kidney Cancer Surgery Practices – HealthCanal.com
|
New Study Likely to Change Kidney Cancer Surgery Practices
HealthCanal.com Sometimes known as a partial nephrectomy, NSS involves the removal of only the cancerous portion of a patient’s kidney when a cancer is at an early stage with small, localized tumors, when patients have already lost one kidney or when they are at risk … |
Qatar Islamic Bank's blood donation day achieves success – AME Info (press release)
|
Qatar Islamic Bank’s blood donation day achieves success
AME Info (press release) Qatar Islamic Bank (QIB), the leading Islamic bank in Qatar, received an enthusiastic response from Qataris and residents marked the successful conclusion of the blood donation day that was held on Sunday 31st March, at QIB Head office at Grand Hamad … |
Biogen Idec erwirbt umfassende Rechte an TYSABRI® – Finanzen.net
|
Biogen Idec erwirbt umfassende Rechte an TYSABRI®
Finanzen.net Des Weiteren verfügt Biogen Idec über die branchenweit tiefstgreifende MS-Pipeline mit Wirkstoffen wie PLEGRIDY™ (Peginterferon Beta-1a), Daclizumab High-Yield Process (DAC HYP) für monatliche subkutane Verabreichung und eine laufende klinische … |
Biosimilars Could Be An Unlikely Boost For Pfizer – Seeking Alpha
Biosimilars Could Be An Unlikely Boost For PfizerSeeking AlphaIn this same earnings call Pfizer CEO also mentions that they are working on 3 other biosimilars but they are not nearly as far along on those molecules as Trastuzumab and Rituximab. As an i…